1. Home
  2. TVRD vs GSIW Comparison

TVRD vs GSIW Comparison

Compare TVRD & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tvardi Therapeutics Inc.

TVRD

Tvardi Therapeutics Inc.

SELL

Current Price

$1.09

Market Cap

15.7M

Sector

Health Care

ML Signal

SELL

GSIW

Garden Stage Limited

SELL

Current Price

$10.41

Market Cap

14.6M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
TVRD
GSIW
Founded
2017
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
14.6M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
TVRD
GSIW
Price
$1.09
$10.41
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $8.88
N/A
AVG Volume (30 Days)
★ 207.0K
3.2K
Earning Date
11-13-2026
08-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.01
N/A
EPS
N/A
★ N/A
Revenue
★ $911,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 959.30
N/A
52 Week Low
$0.77
$0.05
52 Week High
$5.69
$38.55

Technical Indicators

Market Signals
Indicator
TVRD
GSIW
Relative Strength Index (RSI) 50.87 45.40
Support Level $0.85 $9.39
Resistance Level $2.02 $12.32
Average True Range (ATR) 0.17 0.52
MACD 0.05 0.23
Stochastic Oscillator 41.46 45.24

Price Performance

Historical Comparison
TVRD
GSIW

About TVRD Tvardi Therapeutics Inc.

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

About GSIW Garden Stage Limited

Garden Stage Ltd, through its subsidiaries is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; asset management services; investment advisory services; due diligence services; and introduction and referral services. The company operates in a single segment and derives all of its revenue from Hong Kong.

Share on Social Networks: